Acquisition Opportunity Eucalyptus is a high-growth digital health platform that recently attracted attention from Hims & Hers Health for a potential acquisition, signaling strategic value and potential integration opportunities for buyers, investors, or partnership channels seeking scale in telehealth.

Global Telehealth Reach With over one million consultations across Australia, the UK and Germany, Eucalyptus demonstrates established international telehealth operations and potential for cross-border expansion partnerships, licensing, or co-branding opportunities in new markets.

Funding & Scale Significant funding history including a Series B of around A$30 million and total funding of about $120 million, plus ongoing growth initiatives, suggests capacity and readiness for enterprise deals, platform integrations, and larger multi-clinic partnerships.

Tech & AI Collaboration Existing tech stack includes AI-enabled partnerships (Amigo) and data tooling (Google BigQuery, Braze, Cypress), indicating openness to technology integrations, data-driven marketing, and AI-powered care delivery enhancements that could be offered as value-added services.

Expansion & Diversification Recent international expansion into Europe with weight loss products and a portfolio spanning multiple clinics (Pilot, Kin, Software, Juniper) presents opportunities for bundled services, platform licensing, or co-development of new verticals to accelerate revenue growth.